+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model



Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model



Journal of Medical Economics 18(6): 410-419



To project the cost-effectiveness of population-based echo screening to prevent rheumatic heart disease (RHD) consequences. RHD is a leading cause of cardiovascular mortality and morbidity during adolescence and young adulthood in low- and middle-per capita income settings. Echocardiography-based screening approaches can dramatically expand the number of children identified at risk of progressive RHD. Cost-effectiveness analysis can inform public health agencies and payers about the net economic benefit of such large-scale population-based screening. A Markov model was constructed comparing a no-screen to echo screen approach. The echo screen program was modeled as a 2-staged screen of a cohort of 11-year-old children with initial short screening performed by dedicated technicians and follow-up complete echo by cardiologists. Penicillin RHD prophylaxis was modeled to only reduce rheumatic fever recurrence-related exacerbation. Quality-adjusted life years (QALYs) and societal costs (in 2010 Australian dollars) associated with each approach were estimated. One-way, two-way and probabilistic sensitivity analyses were performed on RHD prevalence and transition probabilities; echocardiography test characteristics; and societal level costs including supplies, transportation, and labor. The incremental costs and QALYs of the screen compared to no screen strategy were -$432 (95% CI = -$1357 to $575) and 0.007 (95% CI = -0.0101 to 0.0237), respectively. The joint probability that the screen was both less costly and more effective exceeded 80%. Sensitivity analyses suggested screen strategy dominance depends mostly on the probability of transitioning out of sub-clinical RHD. Two-stage echo RHD screening and secondary prophylaxis may achieve modestly improved outcomes at lower cost compared to clinical detection and deserves closer attention from health policy stakeholders.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057684078

Download citation: RISBibTeXText

PMID: 25629653

DOI: 10.3111/13696998.2015.1006366


Related references

Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model. Lancet. Global Health 2019, 2019

Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circulation. Cardiovascular Quality and Outcomes 6(3): 343-351, 2013

Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart 97(24): 2018-2022, 2012

Cost-Effectiveness Analysis of an Adherence-Promotion Intervention for Children With Leukemia: A Markov Model-Based Simulation. Journal of Pediatric Psychology 43(7): 758-768, 2018

Cost effectiveness of memantine in Alzheimer's disease: an analysis based on a probabilistic Markov model from a UK perspective. Drugs and Aging 21(9): 607-620, 2004

Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model. World Journal of Gastroenterology 14(19): 3021-3027, 2008

Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis. Lancet. Global Health 5(4): E439-E447, 2017

The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model. American Journal of Cardiovascular Drugs 9(6): 383-392, 2010

Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost-Utility Analysis. Journal of the American Heart Association 6(3), 2018

Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure. American Heart Journal 170(5): 951-960, 2016

Echo Screening for Rheumatic Heart Disease. Circulation. Cardiovascular Imaging 12(2): E008818, 2019

The Cost-Effectiveness of Different Hearing Screening Strategies for 50- to 70-Year-Old Adults: A Markov Model. Value in Health 18(5): 560-569, 2016

A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba. Plos One 10(3): E0121363, 2016

Clinical Effect and Cost-Effectiveness of Screening for Asymptomatic Carotid Stenosis: A Markov Model. European Journal of Vascular and Endovascular Surgery 55(6): 819-827, 2018

Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program - A Markov Model. Plos One 8(6): E63894, 2013